Canada: Metformin Clinical Trial

Canada: Metformin Clinical Trial

A Double-Blind, Placebo-Controlled Trial of Metformin in Individuals with Fragile X Syndrome

Researchers are testing the effectiveness of Metformin to help improve daily living for individuals with Fragile X syndrome (FXS).

Q: Why do this study?

We are attempting to further assess Metformin’s safety, as well as the benefits of the drug, which has been shown to improve the symptoms and difficulties which individuals with FXS experience, including: delayed language/cognition, excessive eating, obesity, hypogonadism, and delayed puberty.

Q: What will the participants do?

Commit to a four-month study which includes three clinic visits, and five phone calls while taking Metformin orally. Complete various tasks, questionnaires, and examinations by a physician/research team, as well as have blood drawn, as well as urine and stool samples taken.

Q: Who Can Participate?

Individuals aged 6-25 who have been diagnosed with FXS (and who fit the inclusion/exclusion criteria).

Q: Where is the study being conducted?

There are two sites: the University of Alberta and Ste Justine in Montreal. Travel expenses will be reimbursed.

The principal investigator of this study is Dr. Francois Bolduc, MD, PhD, FRCPC, in the Department of Pediatrics at the University of Alberta.

If you’d like to learn more or apply for this opportunity, please fill out the form to send your contact information to the study coordinators.

If you arrived on this page through a MyFXResearch Portal search, you can close this window and return to your filtered results. Or start a new search here.
View More Opportunities

View All

Study: Family Relationships and Parenting of Children with FXS

The UC Davis MIND Institute is currently recruiting study research participants. The study’s goal is to better understand the ways in which characteristics of mothers and fathers and relationships within the family influence the language learning environment of young boys with Fragile X syndrome.

Survey: Needs and Experiences of Families with Young Children with Fragile X

This survey will help support families in the Early Check study in NC whose newborns have been diagnosed with Fragile X and inform the design of an early intervention program for these babies.

Early Development of Young Children with Fragile X in North Carolina

RTI Int’l and UNC at Chapel Hill are conducting a research study to learn more about early development of young children with Fragile X in North Carolina, and the experiences of their parents when obtaining the diagnosis and early intervention services.

Metformin in Individuals with Fragile X Syndrome

We have preliminary evidence that metformin, a common type 2 diabetes medication, is beneficial for language, cognition, and behavior in both children and adults with Fragile X Syndrome.

Describing Anxiety for People with Fragile X Syndrome

A survey to measure levels of behavior. When someone with FXS is experiencing anxiety, describe what you see and hear, and how the experience impacts your/their quality of life.

Visual Perception Study

Our research is looking at how you see and remember the visual world, and how attention changes what we see. We hope our findings will provide a better understanding of the differences in vision and attention occurring in autism.

By | 2019-07-16T18:51:05+00:00 May 21, 2019|Opportunities for families|Comments Off on Canada: Metformin Clinical Trial